서울바이오시스
092190KOSDAQ57.8 / 100
Reference Date: 2026-09-08
Company InformationBased on 2025 Annual Report
Business Overview
Seoul Biosys provides comprehensive solutions ranging from UV to IR, laser diodes, and VCSELs through six global R&D centers and production infrastructure, with over 7,000 patents protecting its 200nm–1600nm wavelength optical semiconductor technology. The company leads in key markets such as automotive lighting and UV LED, where it holds the top market share, and is projected to grow at a 12% annual rate across six major industries including micro LED and VCSEL.
Number of Employees
193people
Average Salary
60.2M KRW
Score Calculation Basis
Detailed Financial Score
1.8x industry avg (risky)
Well below industry avg
Half of industry avg (excellent)
Avg ▲24.0% (2-year basis)
Avg ▲5.6% (2-year basis)
Avg ROE -23.7% (improving, 3yr)
Detailed News Sentiment
- Positive서울반도체, 유럽·미국 이어 인도에서도 특허침해 승소
서울반도체는 인도에서 광반도체 관련 특허 침해 제품 판매 금지 판결을 얻어 글로벌 시장에서의 경쟁력을 강화했다.
- Positive서울반도체, 인도 기업 상대 광반도체 특허 소송 승리
서울바이오시스와 서울반도체가 인도 기업 오네이트를 상대로 광반도체 특허 침해 소송에서 승소하여 기술 보호 강화.
Detailed Momentum
52w lower range (37%)
1m +31.74% (strong rise)
Volume decreasing
Detailed Disclosure
- Neutral반기보고서 (2026.06)2026-08-14
- Neutral연결재무제표기준영업실적등에대한전망(공정공시)2026-08-10
- Neutral[기재정정]연결재무제표기준영업(잠정)실적(공정공시)2026-08-10
